Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

US Patent 11708416 · Granted Jul 25, 2023

Estimated economic value: $211,855,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonis2025
Nucleic acids encoding anchor modified antibodies and uses thereof2025
Methods of treatment using a leptin receptor agonist antibody2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing 2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhib2025
Antigen-binding proteins that activate the leptin receptor2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025